KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Liabilities and Shareholders Equity (2017 - 2025)

Cardlytics (CDLX) has disclosed Liabilities and Shareholders Equity for 9 consecutive years, with $285.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 27.26% year-over-year to $285.6 million, compared with a TTM value of $1.3 billion through Dec 2025, down 30.96%, and an annual FY2025 reading of $285.6 million, down 27.26% over the prior year.
  • Liabilities and Shareholders Equity was $285.6 million for Q4 2025 at Cardlytics, down from $292.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.3 billion in Q4 2021 and bottomed at $285.6 million in Q4 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $727.7 million, with a median of $634.1 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity soared 573.55% in 2021, then plummeted 45.3% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $1.3 billion in 2021, then tumbled by 45.3% to $691.2 million in 2022, then dropped by 16.94% to $574.1 million in 2023, then plummeted by 31.6% to $392.7 million in 2024, then decreased by 27.26% to $285.6 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for CDLX at $285.6 million in Q4 2025, $292.8 million in Q3 2025, and $361.1 million in Q2 2025.